Mapping the Relationship of White Matter Lesions to Depression in Multiple Sclerosis

[1]  J. McCarthy,et al.  “Brain age” predicts disability accumulation in multiple sclerosis , 2023, Annals of clinical and translational neurology.

[2]  K. Jamison,et al.  The sequence of regional structural disconnectivity due to multiple sclerosis lesions , 2023, bioRxiv.

[3]  Mark C. Anderson,et al.  Lesion network localization of depression in multiple sclerosis , 2023, Nature Mental Health.

[4]  L. Parnetti,et al.  Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction , 2023, Journal of Neurology, Neurosurgery, and Psychiatry.

[5]  M. Schoonheim,et al.  The network collapse in multiple sclerosis: An overview of novel concepts to address disease dynamics , 2022, NeuroImage: Clinical.

[6]  J. Ashburner,et al.  Simultaneous assessment of regional distributions of atrophy across the neuraxis in MS patients , 2022, NeuroImage: Clinical.

[7]  Weiling Zhao,et al.  Distinguish bipolar and major depressive disorder in adolescents based on multimodal neuroimaging: Results from the Adolescent Brain Cognitive Development study® , 2022, Digital health.

[8]  K. Jamison,et al.  Structural disconnectivity from paramagnetic rim lesions is related to disability in multiple sclerosis , 2021, Brain and behavior.

[9]  Joel L. Voss,et al.  Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease , 2021, Nature Human Behaviour.

[10]  Gabriel A. Devenyi,et al.  The ANTsX ecosystem for quantitative biological and medical imaging , 2021, Scientific Reports.

[11]  D. Ontaneda,et al.  Thalamic Injury and Cognition in Multiple Sclerosis , 2021, Frontiers in Neurology.

[12]  I. Williams,et al.  Multiple Sclerosis Phenotypes as a Continuum , 2021, Neurology. Clinical practice.

[13]  E. Leray,et al.  Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition , 2020, Multiple sclerosis.

[14]  D. Ramasamy,et al.  Diagnosis of depression in multiple sclerosis is predicted by frontal–parietal white matter tract disruption , 2020, Journal of Neurology.

[15]  Joel L. Voss,et al.  A Human Depression Circuit Derived From Focal Brain Lesions , 2019, Biological Psychiatry.

[16]  D. Bassett,et al.  Neurocognitive and Functional Heterogeneity in Depressed Youth , 2019, bioRxiv.

[17]  Quanzhen Zhao,et al.  Association between suicide and multiple sclerosis: An updated meta-analysis. , 2019, Multiple sclerosis and related disorders.

[18]  A. Feinstein,et al.  Depression and Suicidality in Multiple Sclerosis: Red Flags, Management Strategies, and Ethical Considerations , 2019, Current Neurology and Neuroscience Reports.

[19]  R. Mark Richardson,et al.  Differential tractography as a track-based biomarker for neuronal injury , 2019, NeuroImage.

[20]  O. Commowick,et al.  White matter abnormalities in depression: A categorical and phenotypic diffusion MRI study , 2019, NeuroImage: Clinical.

[21]  C. Eastwood,et al.  Validation of a case definition for depression in administrative data against primary chart data as a reference standard , 2019, BMC Psychiatry.

[22]  Michael D Fox,et al.  Mapping Symptoms to Brain Networks with the Human Connectome. , 2018, The New England journal of medicine.

[23]  Russell T. Shinohara,et al.  A dual modeling approach to automatic segmentation of cerebral T2 hyperintensities and T1 black holes in multiple sclerosis , 2018, NeuroImage: Clinical.

[24]  Timothy D. Verstynen,et al.  Population-averaged atlas of the macroscale human structural connectome and its network topology , 2018, NeuroImage.

[25]  F. Lublin,et al.  Clinical Course of Multiple Sclerosis. , 2018, Cold Spring Harbor perspectives in medicine.

[26]  John Muschelli,et al.  MIMoSA: An Automated Method for Intermodal Segmentation Analysis of Multiple Sclerosis Brain Lesions , 2018, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[27]  N. Dosenbach,et al.  The frontoparietal network: function, electrophysiology, and importance of individual precision mapping , 2018, Dialogues in clinical neuroscience.

[28]  K. Fujimoto,et al.  Baseline biomarkers of connectome disruption and atrophy predict future processing speed in early multiple sclerosis , 2018, NeuroImage: Clinical.

[29]  Á. Pascual-Leone,et al.  Rostral anterior cingulate cortex is a structural correlate of repetitive TMS treatment response in depression , 2018, Brain Stimulation.

[30]  M. Fox,et al.  Lesion network localization of criminal behavior , 2017, Proceedings of the National Academy of Sciences.

[31]  Peter F. Neher,et al.  The challenge of mapping the human connectome based on diffusion tractography , 2017, Nature Communications.

[32]  L. Lix,et al.  Increased incidence of psychiatric disorders in immune-mediated inflammatory disease. , 2017, Journal of psychosomatic research.

[33]  Nicholas C. Firth,et al.  Progression of regional grey matter atrophy in multiple sclerosis , 2017, bioRxiv.

[34]  Martin Walter,et al.  Detecting Neuroimaging Biomarkers for Depression: A Meta-analysis of Multivariate Pattern Recognition Studies , 2017, Biological Psychiatry.

[35]  T. Powell,et al.  Disability, depression and suicide ideation in people with multiple sclerosis. , 2017, Journal of affective disorders.

[36]  Andrew T. Drysdale,et al.  Resting-state connectivity biomarkers define neurophysiological subtypes of depression , 2016, Nature Medicine.

[37]  Steen Moeller,et al.  The Human Connectome Project's neuroimaging approach , 2016, Nature Neuroscience.

[38]  Yu-Te Wu,et al.  The White Matter Microintegrity Alterations of Neocortical and Limbic Association Fibers in Major Depressive Disorder and Panic Disorder , 2016, Medicine.

[39]  Fang-Cheng Yeh,et al.  Connectometry: A statistical approach harnessing the analytical potential of the local connectome , 2016, NeuroImage.

[40]  S. Morrow,et al.  Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses. , 2015, Journal of affective disorders.

[41]  Á. Pascual-Leone,et al.  Network localization of neurological symptoms from focal brain lesions. , 2015, Brain : a journal of neurology.

[42]  A. Feinstein,et al.  The link between multiple sclerosis and depression , 2014, Nature Reviews Neurology.

[43]  C. Crainiceanu,et al.  Statistical normalization techniques for magnetic resonance imaging , 2014, NeuroImage: Clinical.

[44]  Kurt L. Johnson,et al.  Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis. , 2014, Rehabilitation psychology.

[45]  Bilwaj Gaonkar,et al.  Multi-atlas skull-stripping. , 2013, Academic radiology.

[46]  Thomas Kohlmann,et al.  Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis , 2013, BMC Neurology.

[47]  Anthony Feinstein,et al.  Multiple sclerosis and depression , 2011, Multiple sclerosis.

[48]  Brian B. Avants,et al.  N4ITK: Improved N3 Bias Correction , 2010, IEEE Transactions on Medical Imaging.

[49]  Kathryn R. Cullen,et al.  Altered white matter microstructure in adolescents with major depression: a preliminary study. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[50]  C. Almli,et al.  Unbiased nonlinear average age-appropriate brain templates from birth to adulthood , 2009, NeuroImage.

[51]  A. Compston,et al.  Multiple sclerosis , 2008, The Lancet.

[52]  C. Hewitt,et al.  Screening for Depression in Medical Settings with the Patient Health Questionnaire (PHQ): A Diagnostic Meta-Analysis , 2007, Journal of General Internal Medicine.

[53]  B. Gohier,et al.  Psychiatric side effects of interferon-β in multiple sclerosis , 2006, European Psychiatry.

[54]  N. Lobaugh,et al.  Structural brain abnormalities in multiple sclerosis patients with major depression , 2004, Neurology.

[55]  D. Berg,et al.  Lesion pattern in patients with multiple sclerosis and depression , 2000, Multiple sclerosis.

[56]  A Capdevila,et al.  Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis , 1997, Neurology.

[57]  A. Filouš.  [Diagnosis of multiple sclerosis]. , 1989, Ceskoslovenska neurologie a neurochirurgie.

[58]  D. Reich,et al.  Multiple Sclerosis , 2018, The New England journal of medicine.

[59]  A. Dulamea.  Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis. , 2017, Advances in experimental medicine and biology.

[60]  Antidepressants , 1993, L'Encephale.